Study Evaluating HTC-867 in Healthy Young and Elderly Subjects

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Healthy Subjects

In brief

The purpose of this study is to assess the safety and tolerability of ascending single oral doses of HTC-867 in healthy young and elderly subjects. This study will also evaluate the way the drug enters and leaves the blood and tissues over time and how the drug acts on and in the body in a fasted and fed state.

Key facts

Study ID

NCT00827489

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

72

Starts

2009-01-01

Expected to finish

2009-04-01

Last updated by the study team

2009-09-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Study site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.